Filter
3374
Filtered Results: 3374
Text search:
national
drug
authority
Featured
Recommendations
310
New Publications
978
Language
Document type
No document type
2039
Studies & Reports
516
Guidelines
437
Manuals
160
Strategic & Response Plan
124
Fact sheets
33
Training Material
32
Situation Updates
19
Infographics
5
Resource Platforms
4
Online Courses
3
Brochures
2
Countries / Regions
India
174
Global
108
Kenya
102
Ethiopia
96
Uganda
94
Western and Central Europe
89
Nigeria
67
Liberia
66
South Africa
65
Ghana
62
Sierra Leone
55
Tanzania
55
Latin America and the Carribbean
51
Myanmar / Burma
51
Nepal
50
Zambia
50
Malawi
49
Bangladesh
48
Africa
43
Rwanda
41
Eastern Europe
36
Ukraine
35
Zimbabwe
31
Cambodia
31
South–East Asia Region
29
Namibia
29
Asia
28
Philippines
26
Lesotho
22
Congo, Democratic Republic of
19
Botswana
18
Syria
16
Indonesia
14
Eastern Europe and Central Asia
13
Senegal
12
Mozambique
12
South Sudan
12
Eswatini/ Swaziland
12
Venezuela
11
Burkina Faso
10
East and Southern Africa
10
Russia
10
Haiti
9
Germany
9
West and Central Africa
9
Middle East and North Africa
9
Brazil
9
Colombia
8
Albania
8
Guinea
8
Vietnam
8
Pakistan
8
Laos
7
USA
7
Tajikistan
6
Thailand
6
China
6
Cameroon
6
Afghanistan
6
Western Pacific Region
6
Georgia
6
Moldova
5
Sri Lanka
5
Sudan
5
Central African Republic
5
North Macedonia
4
Mexico
4
Jordan
4
Yemen
4
Iraq
4
Turkey
3
Benin
3
Iran
3
Fiji
3
Jamaica
3
Lebanon
3
Papua New Guinea
3
Palestine
3
Mali
3
Libya
3
Somalia
3
Timor Leste/ East Timor
2
El Salvador
2
Serbia
2
Chile
2
Kyrgyzstan
2
Uzbekistan
2
Peru
2
Morocco
2
Mongolia
2
Armenia
2
Hungary
2
Saudi Arabia
2
North America
2
United Kingdom
2
Portugal
2
Southern Africa
2
Bolivia
2
Argentina
2
Poland
2
Bhutan
2
North Korea
1
Switzerland
1
Australia
1
Kazakhstan
1
Canada
1
Estonia
1
Qatar
1
Bulgaria
1
Italy
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Paraguay
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Egypt
1
Romania
1
Greece
1
Honduras
1
Angola
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1278
Clinical Guidelines
329
Public Health
195
Women & Child Health
145
Key Resources
90
Pharmacy & Technologies
56
Capacity Building
49
Toolboxes
HIV
361
TB
312
Mental Health
281
AMR
205
COVID-19
149
Pharmacy
141
NTDs
99
Rapid Response
79
Caregiver
65
Ebola
58
Planetary Health
51
Refugee
49
NCDs
49
Conflict
45
Global Health Education
39
Disability
33
Polio
17
Zika
16
Natural Hazards
15
Specific Hazards
14
Cholera
14
Health Financing Toolbox
14
Social Ethics
5
Health Financing
1
This report reviews the latest evidence on what works to reduce HIV-related stigma and discrimination through key programmes to reduce stigma and discrimination and increase access to justice in the six settings of focus for the Global Partnership. It includes guidance for national governments and k...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...
.This assessment was conducted using focus group discussion(FGD)with peopleliving with disabilities who were members of the Ethiopian National Association of the Deaf(Person with hearing impairment), Ethiopian National Association of the Deaf -Blind ( Person with hearing and visual impairment), Ethi...
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Maintaining essential health services: operational guidance for the CO...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
Since the launch of the 2012–2020 World Health Organization (WHO) road map for the control, elim-ination and eradication of neglected tropical diseases (NTDs) (1), considerable progress against NTDs has been made. Between 2010 and 2020, the number of people requiring interventions against NTDs glo...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Global Tuberculosis Report 2022 Factsheet
recommended
The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels.
The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area...
The "Questions and Answers on Prevention and control of Alcohol related harm" has been developed by WHO country office in Viet Nam with technical contribution from national and international experts in the field. This publication provides scientific evidences on harms of alcohol use to the health of...
As part of the UN’s data strategy—which seeks to nurture data as a strategic asset for insight, impact and integrity—UNAIDS plays an indispensable role in generating data for effective action against the AIDS pandemic. It leads the
world’s most extensive data collection on HIV epidemiology,...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
The desired impact of the OH JPA is a world better able to prevent, predict, detect and
respond to health threats and improve the health of humans, animals, plants and the
environment while contributing to sustainable development. The OH JPA aims to work
towards this vision in the following way:
...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
The document "Global Report on Diabetes" by the World Health Organization (WHO) provides an in-depth analysis of diabetes as a global health challenge. It covers the rising prevalence of the disease, the associated risk factors, and the increasing burden on healthcare systems, particularly in low- a...
